You are browsing content specific to your location, some treatments may not be available:

Call for an appointment:

1800 103 7555

Fertility
Anti-müllerian hormone variability during ovarian stimulation for IVF: A novel approach to predict fertility treatment outcomes
PUBLICATIONS
Submitted:
Accepted:

Abstract

Melado L, Lawrenz B, Bengum L, et al. Anti-müllerian hormone variability during ovarian stimulation for IVF: A novel approach to predict fertility treatment outcomes. J Reprod Biol Endocrinol. 2018;2(1):33-34.

Anti-Müllerian hormone (AMH) is nowadays one of the most important ovarian reserve markers, useful for individualizing the therapeutic strategy in patients with infertility. In this short review, we have summarized the variability AMH shows during the natural cycle and during ovarian stimulation protocols, looking for the best moment to measure AMH.